Impact of lipoatrophy on quality of life in HIV patients receiving anti-retroviral therapy

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 20, Issue 10, 2008, Pages 1197-1201

  Rajagopalan, Rukmini ^a   Laitinen, David ^a   Dietz, Birgitta ^b  

^a ABBOTT LABORATORIES   (United States)

^b ABBOTT GMBH AND CO KG   (Germany)

Author keywords

Facial fat loss; Health related quality of life True; HIV AIDS; Lipoatrophy

Indexed keywords

ADULT; AFRICAN AMERICAN; ANALYSIS OF VARIANCE; ARTICLE; COHORT ANALYSIS; ETHNICITY; EUROPEAN AMERICAN; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LIPOATROPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE;

ADULT; AGED; ANTI-HIV AGENTS; COHORT STUDIES; FEMALE; HEALTH STATUS; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; YOUNG ADULT;

EID: 56549130063     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120801926993     Document Type: Article

References (17)

1. ACTG. (2007). Metabolic outcomes of ACTG 5142: A prospective, randomized Phase III trial of NRTI-, PI-and NNRTI-sparing Regimens for initial treatment of HIV-1. Presented at the 14th Conference on Retrivirus and Opportunistic Infections, February 25-28, Los Angeles, CA.
2. Ammassari, A., Antinori, A., Cozzi-Lepri, A., Trotta, M.P., Nasti, G., Ridolfo, A.L., et al. (2002). Relationship between HAART adherence and adipose tissue alterations. Journal of Acquired Immune Deficiency Sundrome, 31(Suppl. 3), S140-S144.
3. Bernasconi, E., Boubaker, K., Junghans, C., Flepp, M., Furrer, H.J., Haensel, A., et al. (2002). Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV cohort study. Journal Acquired Immune Deficiency Syndrome, 31, 50-55.
4. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed) (pp. 20-27). Hillsdale, NJ: Lawrence Eribaum.
5. Guaraldi, G., Murri, R., Orlando, G., Orlandi, E., Sterrantino, G., Borderi, M., et al. (2003). Morphologic alterations in HIV-infected people with lipodystrophy are associated with good adherence to HAART. HIV Clinical Trials, 4, 99-106.
6. Lenert, L.A., & Feddersen, M. (2002). Adverse effects of medications and trade-offs between length of life and quality of life in human immunodeficiency virus infection. American Journal of Medicine, 113, 229-232.
7. Mauss, S., Corzillius, M., Wolf, E., Schwenk, A., Adam, A., Jaeger, H., et al. (for the DAGNÄ Lipantiretroviral therapy study group). (2002). Risk factors for the HIV-associated lipodystrophy syndrome in a closed cohort of patients after three years of antiretroviral treatment. HIV Medicine, 3, 49-55.
8. Moyle, G.J., Brown, S., Lysakova, L., & Barton, S.E. (2006). A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy. AIDS, 20, 2043-2050.
9. Nolan, D., Hammond, E., Martin, A., Taylor, L., Herrmann, S., McKinnon, E., et al. (2003). Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy. AIDS, 17, 1329-1338.
10. Powderly, W.G. (2003). Limitations in HIV therapies: Opportunities for improvement. Journal of AIDS, 33, S7-S16.
11. Power, R., Tate, H.L., McGill, S.M., & Taylor, C. (2003). A qualitative study of the psychosocial implications of lipodystrohy syndrome on HIV-positive individuals. Sexually Transmitted Infections, 79, 137-141.
12. Revicki, D.A., Sorensen, S., & Wu, A.W. (1998). Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey. Medical Care, 36(2), 126-137.
13. Reynolds, N.R., Neidig, J.L., Wu, A.W., Gifford, A.L., Holmes, W.C., et al. (2006). Balancing disfigurement and fear of disease progression: Patient perceptions of HIV body fat redistribution. AIDS Care, 18(7), 663-673.
14. Santos, C.P., Felipe, Y.X., Braga, P.E., Ramos, D., Lima, R.O., & Segurado, A.C. (2005). Self-perception of body changes in persons living with HIV/AIDS: Prevalence and associated factors. AIDS, 19 (Suppl. 4), S14-21.
15. Sax, P.E., & Gathe, J.C., Jr. (2005). Beyond efficacy: Impact of combination antiretroviral therapy on quality of life. AIDS Patient Care and STDs, 19(9), 563-576.
16. Tien, P.C., & Grunfeld, C. (2004). What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection. Current Opinion in Infectious Diseases, 17, 27-32.
17. Ware, J.E., Jr., & Kisinski, M., Dewey, J.E. & Gandek, B. (2001). How to score and interpret Single-Item Health Status Measures. A manual for users of the SF-8™ Health Survey. Lincoln, RI: QualityMetric.